Parenteral Nutrition Part 1 Flashcards

1
Q

the delivery of nutrients directly into the bloodstream intravenously

A

Parenteral Nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PN is indicated in conditions that preclude the use of the GIT for more than ____ days

these include ?

A

7-10

a non-functioning GI tract
bowel rest
bowel issues
EN not available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

condition that cause non-functioning GI tract

A

prolonged small bowel ileus
severe malabsorption
intractable vomiting or diarrhea
severe short bowel syndrome
small bowel ischemia
severe GIB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

needing PN for bowel rest from _________ or ___________

A

severe exacerbation of IBD
radiation enteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

bowel indications for PN

A

bowel obstruction
bowel perforation
high output small bowel fistula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PN needed if EN _____ is not feasible or failed trials of EN (________)

A

access
post-pyloric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Contraindications to PN

A

Functioning GIT

Treatment < 7 days

Inability to obtain venous access

Prognosis that does not warrant aggressive nutrition support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

carbohydrate in PN is in form of _______
provides ____ kcal/g
commercially available in concentrations (______)

A

dextrose monohydrate
3.4
5-70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DEXTROSE
______ mg/kg/min for stable patients
_____ for patients with DM or hyperglycemia
_____ mg/kg/min for critically ill patients

A

4-5
low end (4)
<4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Excessive dextrose/carb administration can results in _________, ________, and ______.

A

hyperglycemia
increased CO2 production
fatty liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

calculation for maximum CHO dose

A

4 or 5 mg X wt in kg X 1440 (min in day)

divide by 1000 to convert to g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

You have a 60 kg patient who has Type 1 DM. What is the max amount of CHO the patient should be given in a day?

A

345.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Source of Protein in PN is ___________
Contain all ____ and some ____
Concentrations: ______%
Provides ___ kcal/g

A

crystalline amino acids
EAA
NEAA
3% - 20%
4.0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Currently ________ is not included in crystalline AA solutions because it is ____

A

glutamine
unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lipids in PN are called _________

A

Lipid injectable emulsions (ILEs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Source of ILEs: _________
usually ________ and also may contain ______ and ________

A

Long-chain fatty acid emulsions
Soybean oil

egg yolk phospholipid & glycerol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ILEs are _____ dense and _______

A

Calorie
Isotonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Alternative Lipid Injectable Emulsions Available in the U.S. is a __________ called ________.

A

mixed oil lipid injectable emulsion
smoflipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

smoflipid consists of

A

30% soybean oil
30% MCT oil
25% olive oil
15% fish oil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

There is a mixed oil PN formula for pediatric patients with _______

this formula is called ______

A

PN associated cholestasis
omegaven

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Omegaven is rich in _______ and believed to have _________ effects

A

omega-3 FA
anti-inflammatory effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

most commonly used percent of lipid emulsion

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

10% Lipid emulsion:
_____ kcal/mL or ____ kcal/g

A

1.1
11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

20% Lipid emulsion:
____ kcal/mL or ___ kcal/g

A

2.0
10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
30% Lipid emulsion [only available for ______]: ____ kcal/mL or ___ kcal/g
Total Nutrient Admixture (TNA) 3.0 10
26
minimum requirements _____% of total kcal needs from _____ acid ____% of total kcal needs provided as lipid in PN should prevent EFAD
2-4 linoleic 10
27
OPTIMAL FAT INTAKE ______% of kcal from fat; or ____ g/kg/d for stable patients and ___ g/kg/d for critically ill patients Reduces the complications of solely dextrose-based PN=>hyperglycemia, respiratory compromise Provide _____, ____ infusion (>___ hrs/d)
20-30 1 <1 slow, continuous 10
28
CONSEQUENCES OF FAT OVERLOAD
Hypertriglyceridemia
29
hypertriglyceridemia from fat overload can cause ________, ________, ________, and ______
Impaired immune response Hepatic steatosis Acute Pancreatitis Impaired vascular integrity
30
impaired immune system from fat overload can cause __________________ impaired immune system function comes from_______, which inhibits _______ immune response
hepatic reticuloendothelial system (RES) dysfunction linoleic acid cell-mediated
31
CONTRAINDICATIONS OF LIPIDS - ________ - ________ use with caution in _______ and ______
Egg allergy severe hyperlipidemia severe sepsis multiple organ dysfunction syndrome (MODS)
32
Lipid clearance is monitored by ______ check levels _____________
serum TG prior to initiation and after
33
Hold ILE if serum TG level is >____ mg/dL If serum TG continues to be >_____ mg/dL=> ______________________
400 400 limit ILE to minimum amount to prevent EFAD
34
Cofactor necessary for the transport of LCFA for beta-oxidation is _______
carnitine
35
is carnitine in PN formulas?
no
36
At risk for deficiency of carnitine=> _______ and _______
premature infants dialysis patients
37
Deficiency of carnitine can result in... _______ ______ ______ ______
hypertriglyceridemia fatty liver muscle weakness cardiomyopathy
38
How to treat carnitine deficiency
An IV form of L-carnitine
39
Vitamins provided together in a ____ dose of “standard vitamins” Requirements ____ from DRI’s Parenteral requirements for many vitamins are ______ for many of the vitamins due to __________ in PN
10 ml differ higher decreased stability
40
ASPEN Recommendations for PN vitamins
*dont think I need to know this* Thiamin: 6 mg Riboflavin: 3.6 mg Niacin: 40 mg Folic acid: 600 mcg Pantothenic acid: 15 mg Pyridoxine: 6 mg Vitamin B12: 5 mcg Biotin: 60 mcg Ascorbic acid: 200 mg Vitamin A: 990 mcg Vitamin D: 5 mcg Vitamin E: 10 mg Vitamin K: 150 mcg
41
Trace elements Commercial preparation: _____ ml/day Parenteral requirements for most trace elements are ______ than the DRIs because there is _________ when given IV
1 lower 100% absorption
42
ASPEN Recommendations for PN Trace Elements
Zinc Copper Manganese Chromium Selenium
43
Zinc: ___ mg/d Additional __ mg/d for _____ patients Patients with EC fistulae, diarrhea, & intestinal drainage may require up to _____ of lost fluid
3-5 2 hypermetabolic 12–17 mg/L
44
Copper: _____ mg/d
0.3-0.5
45
Manganese: ___ mcg/d
55
46
Chromium: ____ mcg/d
10-15
47
Selenium: _____ mcg/d
60-100
48
Not routinely included in standard trace element preparations=> _____, ____, and ____ Cholestatic liver disease=> ___ and ___ should be omitted from PN
Iron Iodine Molybdenum Cu & Mn
49
Daily Electrolyte Guidelines for PN include which ones
sodium potassium magnesium calcium phosphorous chloride acetate
50
Sodium: _____ mEq/kg
1-2
51
Potassium: ____ mEq/kg
1-2
52
Magnesium ____ mEq
8-20
53
Calcium ____ mEq
10-15
54
Phosphorus ____ mmol
20-40
55
Chloride: _____
as needed to maintain acid-base balance
56
Acetate: ______
as needed to maintain acid-base balance
57
Available forms of Sodium:
phosphate chloride acetate
58
Available forms of Potassium:
phosphate chloride acetate
59
Available forms of Calcium:
gluconate
60
Available forms of Magnesium:
sulfate
61
ELECTROLYTE ADJUSTMENTS May need to increase if abnormal ______(urinary, GI or dermal) or ______ May need to decrease if=> _____ or _____ Individual electrolytes can be adjusted to correct imbalances
losses refeeding syndrome renal failure CHF
62
ACID-BASE BALANCE Usually maintained by using ______ & ______ (___ ratio) Metabolic acidosis=> provide more _____ Metabolic alkalosis=>provide more _____
chloride acetate 1:1 acetate chloride
63
Major problem in the U.S. is PN shortages Shortages due to=> manufacturing issues, company ________, drug recalls, companies can’t keep up with _____ Affecting both macro- and micronutrients Resulting in=> serious adverse patient outcomes - Use of suboptimal alternatives, errors, inadequate nutrition & deficiencies
closures demand
64
Strategies for Managing PN Shortages 1. Assess each patient for need for PN 2. Use _____________ when possible 3. Assess at individual level the need for _________ 4. Prioritize patients 5. Rationing
oral or enteral nutrients specific nutrients
65
Rationing examples providing ____% dose of MVI MVI ____/week; ILE ___/week If MVI not available, administer individual parenteral _____, _____, _____, and _____ daily.
50 3x 1x thiamin ascorbic acid pyridoxine folic acid
66